Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 10, 2019
Equillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled Asthma
LA JOLLA, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat ...
July 10, 2019
Arcturus Therapeutics to Participate in Two Panels at the ROTH RNA Revolution Conference
SAN DIEGO, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development ...
July 9, 2019
Kuros Biosciences Signs Agreement with Surgical Specialties on Distribution of MagnetOs in Australia and New Zealand
SCHLIEREN (ZURICH), Switzerland, July 09, 2019 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) today announced that its Dutch subsidiary, Kuros Biosciences BV, has signed a distribution ...
July 9, 2019
Nicox Receives $3 million Milestone Payment from Eyevance for ZERVIATE in the U.S.
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that it has received a $3 million milestone payment from partner Eyevance Pharmaceuticals, ...
July 9, 2019
Check-Cap Announces Positive Final Results from Its Post-CE Approval Study of the C-Scan® System
ISFIYA, Israel, July 9, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (CHEK) (NASDAQ:CHEKW), (NASDAQ:CHEKZ), a clinical stage medical diagnostics company advancing the development ...
July 9, 2019
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
GAITHERSBURG, Md., July 09, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced that it has entered into an agreement to ...
July 9, 2019
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
RALEIGH, N.C., July 09, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions, today ...
July 9, 2019
Immutep Raises A$10 Million Via Private Placement and Underwritten Entitlement Offer
NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “Company”), an Australian biotechnology company developing novel immunotherapy treatments ...
July 9, 2019
Heat Biologics Completes Enrollment in Phase 2 Non-Small Cell Lung Cancer Trial
DURHAM, NC / ACCESSWIRE / July 9, 2019 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing therapies designed to activate a patient’s immune system ...
July 9, 2019
NICE Issues Draft Guidance on the Use of gammaCore for Cluster Headache
LONDON and BASKING RIDGE, N.J., July 09, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a global commercial-stage bioelectronic medicine company, today announced that the National ...
July 9, 2019
CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data
BERKELEY HEIGHTS, N.J., July 09, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
July 9, 2019
Cellectar Receives FDA Fast Track Designation for CLR 131 in Diffuse Large B-Cell Lymphoma
FLORHAM PARK, N.J., July 09, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
July 9, 2019
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Daix (France) July 9, 2019 – Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas ...
July 9, 2019
Albireo Provides Mid-Year Clinical Development Update
BOSTON, July 09, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, provided an ...
July 9, 2019
Inspire Medical Systems, Inc. to Report Second Quarter 2019 Financial Results on August 6, 2019
MINNEAPOLIS, July 09, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
July 8, 2019
Inspire Medical Systems, Inc. Announces UnitedHealthcare Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea
MINNEAPOLIS, July 08, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (the “Company” or “Inspire”), a medical technology company focused on the development and ...
July 8, 2019
Zogenix Completes Enrollment in Phase 3 Trial of FINTEPLA® in Lennox-Gastaut Syndrome
EMERYVILLE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has completed ...
July 8, 2019
TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism based therapies (CMBTs™), announced that ...
July 8, 2019
HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0
TUCSON, Ariz., July 08, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today ...
July 8, 2019
STRATA Skin Sciences Announces Direct Distribution Contract with Kosmo Meditech in Korea
HORSHAM, Pa., July 08, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to ...
Page 18 of 169